Abiopharma

Clinical trial NCT06315582 updates: 1. completion date: 2026-10-26 → 2026-12-01 2. primary completion date: 2026-08-26 → 2026-12-01

Clinical trial NCT05174221: start date: 2022-11-09 → 2022-08-16.

Clinical trial NCT06754046: collaborators added: University of Michigan.

Clinical trial NCT07107022 updates: 1. completion date: 2027-12-01 → 2028-04-01 2. primary completion date: 2027-10-01 → 2028-01-01

Clinical trial NCT03737929 updates: 1. status: RECRUITING → TERMINATED 2. completion date: 2025-12-31 → 2024-01-29 3. primary completion date: 2025-12-31 → 2024-01-29 4. enrollment: 228 → 7 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05996835 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-05-20 → 2026-05-14 3. enrollment: 320 → 316 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT07549139 updates: 1. start date: 2026-05-31 → 2026-06-30 2. completion date: 2027-11-30 → 2027-12-31 3. primary completion date: 2027-11-30 → 2027-12-31 4. primary purpose: SCREENING → HEALTH_SERVICES_RESEARCH

Clinical trial NCT06502561 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2025-12-01 → 2025-11-17 3. enrollment type: ESTIMATED → ACTUAL 4. allocation: NON_RANDOMIZED → RANDOMIZED

Clinical trial NCT02521103 updates: 1. enrollment: 145 → 254 participants 2. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT05434689 updates: 1. completion date: 2026-10-01 → 2028-08-01 2. primary completion date: 2026-04-01 → 2028-08-01